1. Home
  2. ATXS vs NWPX Comparison

ATXS vs NWPX Comparison

Compare ATXS & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • NWPX
  • Stock Information
  • Founded
  • ATXS 2008
  • NWPX 1966
  • Country
  • ATXS United States
  • NWPX United States
  • Employees
  • ATXS N/A
  • NWPX N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • ATXS Health Care
  • NWPX Industrials
  • Exchange
  • ATXS Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • ATXS 401.2M
  • NWPX 420.8M
  • IPO Year
  • ATXS 2015
  • NWPX 1995
  • Fundamental
  • Price
  • ATXS $7.52
  • NWPX $52.16
  • Analyst Decision
  • ATXS Buy
  • NWPX Hold
  • Analyst Count
  • ATXS 6
  • NWPX 1
  • Target Price
  • ATXS $32.00
  • NWPX $55.00
  • AVG Volume (30 Days)
  • ATXS 298.2K
  • NWPX 69.6K
  • Earning Date
  • ATXS 08-12-2025
  • NWPX 10-29-2025
  • Dividend Yield
  • ATXS N/A
  • NWPX N/A
  • EPS Growth
  • ATXS N/A
  • NWPX 32.83
  • EPS
  • ATXS N/A
  • NWPX 3.32
  • Revenue
  • ATXS N/A
  • NWPX $499,125,000.00
  • Revenue This Year
  • ATXS N/A
  • NWPX $4.00
  • Revenue Next Year
  • ATXS N/A
  • NWPX $3.96
  • P/E Ratio
  • ATXS N/A
  • NWPX $15.71
  • Revenue Growth
  • ATXS N/A
  • NWPX 5.83
  • 52 Week Low
  • ATXS $3.56
  • NWPX $36.97
  • 52 Week High
  • ATXS $12.92
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 64.14
  • NWPX 62.14
  • Support Level
  • ATXS $6.50
  • NWPX $50.52
  • Resistance Level
  • ATXS $6.82
  • NWPX $54.26
  • Average True Range (ATR)
  • ATXS 0.44
  • NWPX 1.37
  • MACD
  • ATXS 0.07
  • NWPX -0.36
  • Stochastic Oscillator
  • ATXS 96.62
  • NWPX 48.15

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

Share on Social Networks: